Jpmorgan Chase & Co »

Verrica Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $305 47 6.51
2026-03-31 $224 47 4.77

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Verrica Pharmaceuticals

Caligan Partners
Cannell Capital
Affinity Asset Advisors
Velan Capital Investment Management
Armistice Capital
Boothbay Fund Management
Vanguard Capital Management
Mariner Wealth Advisors
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Two Sigma Investments
State Street Corporation
Northern Trust
DAFNA Capital Management

View all funds holding Verrica Pharmaceuticals